From 30 August to 3 September 2008 the 21st Congress of the European College of Neuropsychopharmacology (ECNP) will be held in Barcelona, Spain. This Congress is the largest annual meeting on psychopharmacology and mental disorders in Europe of a high scientific standard, attended by more than 6,000 participants (clinical and basic scientists such as psychiatrists, neurologists, psychologists and neuroscience researchers) from all over the world.
This year's programme will present not only the latest findings and breakthroughs in neuropsychopharmacology and related disciplines in both preclinical and clinical settings, but also cover the various aspects of pharmacotherapy of brain disorders and their impact on the quality of life of patients with psychiatric and neurological disorders.
In this regard, the scientific programme will comprise, among others, the following topics:
Neurogenesis and stem cells
Neurocognitive insights in substance addiction
Current trends in neuroimaging and psychosis
Genetic causes of autism
Pharmacological challenges for understanding affective and stress-related disorders
Furthermore, the educational updates at the congress will deal with the impact of current social, economic and cultural changes on mental health care (e.g. neuroethics, effects of migration etc.).
For further information about the provisional scientific programme, please visit the ECNP website: ecnp.eu/.
The exciting scientific programme along with the congress site Barcelona, one of the most beautiful cities in Southern Europe with an amazing cultural energy and a passion for progress, will make this congress an outstanding and unforgettable event.
We hope you will find this meeting of interest and a valuable source of information for spreading the spirit of scientific adventure and discovery!
We are looking forward to welcoming you in Barcelona!
Source: Sonja Mak
European College of Neuropsychopharmacology
Комментариев нет:
Отправить комментарий